MariMed Inc. (MRMD)

OTCMKTS: MRMD · Delayed Price · USD
+0.005 (1.08%)
Jun 24, 2022 4:00 PM - Market closed

Company Description

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally.

The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand.

It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

MariMed Inc.
MariMed Logo
Country United States
Industry Drug Manufacturers-Specialty & Generic
Sector Health Care
Employees 260

Contact Details

10 Oceana Way
Norwood, MA 02062
United States
Phone 617 795 5140

Stock Details

Ticker Symbol MRMD
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 1522767

Key Executives

Name Position
Robert N. Fireman Co-Founder, Chairman, President and Chief Executive Officer
Jon R. Levine Co-Founder, Chief Administrative Officer, Secretary and Director
Timothy Shaw Chief Operating Officer
Susan Villare CPA Chief Financial Officer
Jonathan W. Rider Chief Information Officer
Steve Wayne West Vice President of Investor Relations
Howard Schacter Chief Communications Officer
Sara Gullickson Vice President of Marketing
Ryan Crandall Senior Vice President of Sales and Chief Product Officer
Charles Holt Finnie Chief Strategy Officer

Latest SEC Filings

Date Type Title
May 18, 2022 3 Initial statement of beneficial ownership of securities
May 18, 2022 8-K Current report
May 16, 2022 8-K Current report
May 10, 2022 10-Q Quarterly report [Sections 13 or 15(d)]
Apr 14, 2022 8-K Current report
Mar 21, 2022 8-K Current report
Mar 16, 2022 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 14, 2022 4 Statement of changes in beneficial ownership of securities
Jan 14, 2022 4 Statement of changes in beneficial ownership of securities
Jan 5, 2022 8-K Current report